ANXA2 and myeloid sarcoma: The findings of a study conducted in 2018 indicate a downregulation of circRNA profiles, specifically ANXA2 circRNAs (circ_0005402 and circ_0035560), in the bloodstream of individuals diagnosed with MS [87].